Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Stopped early · Phase 3

Conditions studied: Kidney Transplant

In brief

The purpose of this study is to determine if one drug is superior to another with regard to safety and the preservation of renal function after a kidney transplant.

Key facts

Study ID

NCT00137345

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

500

Starts

2005-06-01

Expected to finish

2006-08-01

Last updated by the study team

2013-02-08

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Dialysis patients who will be receiving their first kidney transplant
• Weight over 88 pounds (lbs.)

You may not qualify if…

• Very high cholesterol levels
• Obesity
• Organ donor over 65 years of age if living; over 60 years of age if cadaveric.

Where it is running

• Study site — San Francisco, California, United States
• Study site — Denver, Colorado, United States
• Study site — New Haven, Connecticut, United States
• Study site — Gainesville, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Portland, Maine, United States
• Study site — Springfield, Massachusetts, United States
• Study site — Detroit, Michigan, United States
• Study site — New York, New York, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Durham, North Carolina, United States
• Study site — Cleveland, Ohio, United States
• Study site — Cleveland, Ohio, United States
• Study site — Toledo, Ohio, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Providence, Rhode Island, United States
• Study site — Charleston, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Buenos Aires, Capital Ferderal, Argentina
• Study site — Buenos Aires, Capital Ferderal, Argentina
• Study site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.